Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from diabetes

Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soon

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabetes, heart disease, and infections. This move aims to reduce treatment costs for millions of patients managing chronic illnesses, with benefits expected to reach consumers within two to three months as new…

The Economic Times

Medicare Drug Savings Surge: 1 in 3 Seniors Now Pays Less Than $35 a Month for Insulin—Here’s How

Nationwide, an estimated 3.5 to 4 million older adults (seniors aged 65 and older) rely on insulin to manage their diabetes. Somewhere around one in...

Saving Advice

MannKind Wins FDA Approval for Afrezza in Children, Opening Pediatric Diabetes Market

MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration has approved Afrezza for pediatric patients with diabetes ages 6 and older, expanding the inhaled mealtime insulin’s label into children and adolescents. Chief Executive Officer Michael Castagna called the decision “a truly historic

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

India’s GLP-1 Weight Loss Drug Problem Nobody Is Warning You About

A 26-year-old marketing executive in Mumbai loses 14 kilos in three months. Her Instagram fills with compliments. Friends ask for her “secret.” She smiles and says it is just discipline and calorie control. What she does not mention is the weekly injection sitting inside her refrigerator. Across India, GLP-1 drugs…

MyLifeXP

Could GLP-1 Drugs Do More Than Aid Weight Loss? Some Studies Link Them to Lower Tumor Risk

GLP-1 medications already changed the conversation around weight loss, diabetes care, and metabolic health. Now researchers explore an even more intriguing question: could these drugs influence cancer risk as well. Early studies continue to spark interest because they show patterns that go beyond appetite control and blood sugar regulation.

Clever Dude

Don’t Ignore This: Why Professional Primary Care Services Are Essential for Better Health

Many health conditions begin quietly without obvious symptoms. People often assume they are healthy simply because they do not feel sick, but hidden issues such as high blood pressure, diabetes, and heart disease can slowly develop over time.

inkl

The medical condition ‘rising twice as fast’ among UK women

IN FULL

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

‘I had gestational diabetes during my pregnancy. Six years later, I’ve yet to receive any follow-up care’

Gestational diabetes usually disappears after birth, although patients face a higher risk of developing type 2 diabetes

The Independent UK

Type 2 diabetes rates ‘rising twice as fast in younger women’

It has been suggested that the figure could be down to ‘little or no follow-up care’ for those who develop the condition while pregnant.

Evening Standard

Heatwave warning for millions using insulin, metformin and antidepressants

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning that high temperatures can compromise the effectiveness of medicines and impact how the body responds to them, particularly for individuals managing long-term conditions. Overheating: Many medicines require storage below 25°C, as heat can degrade active ingredients in various…

The Independent UK

'Game-changing' diabetes treatment approved

Australians living with an early stage of type 1 diabetes can now be treated with the first non-insulin drug saving them years of needles.

AAP

What Happens to Your Body After 3 Days in 45°C Heat

When the temperature climbs to 45°C, your body enters survival mode. Sweating, increased heart rate, fatigue, headaches, and irritability are not random summer discomforts. They are biological alarms. Most people think heat becomes dangerous only when someone collapses outdoors. But doctors warn that damage often starts much earlier and builds…

MyLifeXP

Are Wall Street Analysts Bullish on Insulet Stock?

Although Insulet has lagged the broader market over the past year, Wall Street analysts remain strongly optimistic about the company’s long-term growth prospects.

Barchart

GLP-1s Now Linked To Lower Risk Of 4 Different Cancerous Tumors

What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...

Saving Advice

Get all your
news in one place.

100's of premium titles.
One news app.

MyLifeXP

5 People Who Should Never Eat Papaya: Hidden Dangers You Should Know About

Papaya has built a reputation as one of the healthiest fruits in the world. Rich in vitamin C, antioxidants, potassium, and digestive enzymes, it’s often recommended for glowing skin, better digestion, and improved immunity. Whether eaten ripe as breakfast or consumed raw in salads, papaya has become a staple in…

The Independent UK

‘Beef. It’s what’s for dinner’: Previous health risks linked to the red meat debunked

More than 36 million Americans live with Type 2 diabetes

Budget and the Bees

GLP-1 Drugs Could Soon Treat Heart Failure and Peripheral Artery Disease—FDA Approvals Coming

GLP-1 drugs are no longer just weight-loss and diabetes medications. Researchers are now studying whether these blockbuster treatments can help people living with heart failure and peripheral artery disease (PAD), two serious conditions affecting millions of Americans. That shift could reshape how doctors manage cardiovascular disease in the coming years.…

The Economic Times

Why are Indians suddenly buying more vitamins after starting Ozempic-like weight loss drugs?

Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weight-loss and diabetes medicines. Doctors are advising patients on these drugs to take multivitamins and protein supplements. This is to prevent nutritional deficiencies and muscle loss due to reduced food intake. Sales…

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

Insurer denies Rs 20 lakh life insurance claim over diabetes non-disclosure; woman fights back and wins; here’s why

A Delhi woman's Rs 20 lakh life insurance claim, denied due to alleged non-disclosure of diabetes and kidney diseases, was upheld by the State Consumer Commission. The insurer failed to provide sufficient proof of deliberate concealment, leading to a ruling in favor of the policyholder.

Evening Standard

Our top-rated berberine supplement could support your metabolic health – here's what to know

The supplement has become increasingly popular for help managing numerous health issues

The Economic Times

Stocks in news: ITC, Nykaa, Lenskart, Ola Electric, IndusInd Bank

Markets saw a volatile session with Nifty trading below the 23,800-24,000 resistance zone, though select heavyweight buying limited downside. Several companies like ITC, Nykaa, and IndusInd Bank are in focus due to Q4 results and news developments, including Lenskart's profit decline and Dr. Reddy's new diabetes drug launch.

The Economic Times

Dr Reddy's launches oral semaglutide biosimilar Obeda in India

Dr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This innovative treatment offers patients the ease of a once-daily oral dosage, available in various strengths to effectively enhance glycaemic control. Dr.

The Guardian - UK

Plantwatch: how goat’s rue inspired super drug for everything from diabetes to obesity

Galegine compound in plant formed blueprint for metformin drug, but without the toxic side-effects

The Conversation

Stem cells have potent potential for diabetes treatment

Humans have around 30 trillion cells in our adult bodies. Amazingly, each of these cells came from a handful of about 100 stem cells in the earliest days of development. The ability of these embryonic stem cells to turn into any cell type makes them pluripotent — something that researchers…

The Guardian - UK

NHS rollout of artificial pancreas narrows inequality in diabetes care

People from deprived and minority ethnic backgrounds have better access to device than for previous technologies

1 2 3 4 5

People

Reddy

25 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.